Gallant Secures $18 Million to Launch Innovative Stem Cell Treatments for Pets Gallant raises $18 million in Series B funding to advance ready-to-use stem cell therapies for pets, targeting chronic diseases effectively.

Gallant Secures $18 Million to Launch Innovative Stem Cell Treatments for Pets #United_States #San_Diego #Veterinary_Medicine #Gallant #Stem_Cell_Therapies